OSUR
ORASURE TECHNOLOGIES INC
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$3.68
+1.94%Year over year
Reported trailing growth
- Revenue
- -18.9%
- EBITDA
- +2.7%
- EBIT
- +4.7%
- EPS
- -2.9%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +16.2%
- EBITDA
- -13.5%
- EPS
- -18.8%
Three-year CAGR
- Revenue
- -33.3%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026